中恒集团：关于控股孙公司获得药品补充申请批准通知书的公告

Group 1 - The core point of the article is that Zhongheng Group announced the approval of a supplemental application for Sodium Lactate Ringer's Injection (500ml) by its subsidiary Hunan Kangyuan Pharmaceutical Co., Ltd. from the National Medical Products Administration [2] Group 2 - The approval signifies a regulatory milestone for Hunan Kangyuan Pharmaceutical, enhancing its product portfolio in the pharmaceutical market [2] - This development may lead to increased market competitiveness and potential revenue growth for the company [2] - The product is expected to meet the growing demand for intravenous solutions in clinical settings [2]